Lupus syndrome, hypothyroidism and bullous skin lesions after interferon alfa therapy for hepatitis C in a haemodialysis patient

Abstract

Lupus syndrome, hypothyroidism and bullous skin lesions after interferon alfa therapy for hepatitis C in a haemodialysis patient Sir, Interferon alfa (IFN-a) is a cytokine available for the treatment of malignant diseases and hepatitis B and C. Major complications of this drug include the occurrence of autoimmune disease w1x.